Research at QBRI
Discover and develop strategies for early diagnosis and therapeutic interventions for neurological disorders, with an emphasis on autism in Qatar and beyond.
Learn MoreTranslate discoveries into prevention, diagnosis, and treatment strategies for diabetes and associated disorders in Qatar and beyond.
Learn MoreDevelop diagnostic tools and therapeutic strategies to optimize cancer care with a focus on breast cancer in Qatar and beyond.
Learn MoreQBRI’s core facilities are positioned as modern, efficient, reliable, and tightly networked shared resource laboratories that guarantee optimal support and scientific progression on several levels.
Learn MoreNews and Insights

QBRI Journal Article Achieves High Impact Factor
Research led by Dr. Yongsoo Park and his team at the Qatar Biomedical Research Institute (QBRI) at Hamad Bin Khalifa University (HBKU) has been published in...
Events
QBRI stands as a biomedical research institute dedicated to addressing pressing health challenges in the region. Recognizing the underrepresentation of Arab populations in research, our mission extends beyond borders. We aspire to elevate QBRI into a global nexus for biomedical and translational research, fostering extensive collaborations worldwide. I take pride in our endeavors, propelling us towards enhancing healthcare in Qatar and beyond.
Dr. Omar Albagha
Acting Executive Director
Uniquely positioned within Qatar’s biomedical R&D landscape, QBRI serves as a cornerstone for excellence in research, entrepreneurial innovation, and clinical translation in the areas of cancer, diabetes, and neurological disorders—key health challenges with significant unmet needs in the local population. As Director of QBRI’s Translational Oncology Research Center (TORC), my ambition is to advance the development and implementation of precision oncology in Qatar. I aim to foster multi-level collaborations and elevate TORC’s basic, translational, and clinical research, with the ultimate goal of delivering groundbreaking discoveries and targeted therapies to cancer patients.
Dr. Vladimir L. Katanaev
Scientific Director, Translational Oncology Research Center
QBRI features multi-interdisciplinary infrastructures and aims to enhance health care management for diabetes, cancer, and neurological disorders by conducting cutting-edge research and translating discoveries into clinical settings—thereby improving patient well-being and enabling the implementation of precision medicine. As Scientific Director of the Diabetes Research Center (DRC), I aspire to propel the DRC to a new level in line with global scientific standards, mobilize international collaborations, drive breakthroughs in precision diabetes care, and develop effective strategies for the prevention and intervention of metabolic disorders such as obesity.
Dr. Cong-Yi (CY) Wang
Principle Investigator and Scientific Director, Diabetes Research Center